RAD ONC MB 1 - Progress Notes (Scribe) | 2022-08-06 16:30:00
Radiation Oncology Follow-Up    Name: ***** *****  *****: *****  DOB: 10/09/1954  Referring Physician: ***** ***** *****, MD   Primary Care Physician: ***** *****, MD   DOS:       08/06/22  CSN:       *****    Diagnosis:  No diagnosis found.   Cancer Staging   Malignant neoplasm of base of tongue (CMS code)  Staging form: Pharynx - HPV-Mediated Oropharynx, AJCC 8th Edition  - Clinical: Stage III (*****, *****, *****) - Signed by ***** *****-***** *****, MD on 10/16/2020          HPI  ***** ***** is a 67 y.o. male never smoker diagnosed on 08/29/2020 with squamous cell carcinoma of the right base of tongue ***** ***** Stage III, s/p chemoradiation 70 Gy with weekly cisplatin 40 mg/m2 x 5 completed 12/23/2020. He was last seen on 01/29/22 and presents for follow-up.    Interval History:  01/29/22: Previous Rad Onc Visit-  Pt had no evidence of residual or recurrent disease on imaging or exam.     06/12/22: OHNS Dr. *****  ***** ***** undetectable    08/03/22: CT Neck W-  IMPRESSION:   1.  Compared to 10/03/2021, no local or nodal recurrence of disease. Specifically, no recurrent disease in the base of tongue.   2.  Continued decrease in size of centrally necrotic right level 2 lymph node. No new metastatic cervical lymphadenopathy.  --CT Chest W--  IMPRESSION:   No evidence of intrathoracic metastatic disease.    ROS  Dental care: *****  Head/neck pain: none  ***** of taste: not normal; some ***** like Japanese food tastes normal  Salivary function: good, ***** one tablet a day; never got pilocarpine  Swallowing: normal  Diet/weight: stable, no limits to diet  Hearing: normal    Past Medical History:   Diagnosis Date    Anxiety     Cancer (CMS code) squamous cell carcinoma    Chronic kidney disease GFR 58    OSA (obstructive sleep apnea) 2005    New CPAP on April 2017    Renal insufficiency      Past Surgical History:   Procedure Laterality Date    COLONOSCOPY       Allergies/Contraindications 
   Allergen Reactions    Glycopyrrolate Hives    Ondansetron Hcl      Current Outpatient Medications   Medication Sig Dispense Refill    fluoride, sodium, (***** 5000 BOOSTER PLUS) 1.1 % dental paste ***** TRACE AMOUNT ON TEETH TWICE DAILY. ***** OUT EXCESS. DO NOT EAT DRINK OR RINSE FOR 30 MINUTES. 100 mL 11    multivitamin with minerals tablet Take by mouth      netarsudiL-latanoprost (*****) 0.02-0.005 % DROPSOLN       zinc gluconate 50 mg tablet Take 50 mg by mouth daily      pilocarpine (SALAGEN) 5 mg tablet Take 1 tablet (5 mg total) by mouth 3 (three) times daily 30 tablet 3     No current facility-administered medications for this encounter.     Social History     Tobacco Use   Smoking Status Never   Smokeless Tobacco Never             Vitals: BP 120/87 (BP Location: Left upper arm, Patient Position: Sitting, Cuff Size: Adult)  | Pulse 86  | Temp (!) 35.9 C (96.6 F) (Temporal)  | Resp 18  | Wt 73.3 kg (161 lb 9.6 oz)  | SpO2 100%  | BMI 24.69 kg/m   Pain score:  0 /10  Karnofsky Performance Status (KPS): 80% - Normal activity with some difficulty, some symptoms or signs    Physical Exam  General: Well nourished, in no acute distress, alert and interactive  Head: Normocephalic and atraumatic    Oral cavity: Good dentition, moist mucosa, no lesions on anterior tongue, good movement anterior tongue  Oropharynx: No mucosal lesions, no tonsillar enlargement, symmetric palate rise    Neck: No fibrosis, no lymphedema, no hyperpigmentation. Supple, trachea midline, full active range of motion  Lymphatics: No cervical or supraclavicular lymphadenopathy.     Fiberoptic *****:  Indication: Requirement for full, in depth, close up view of upper aerodigestive tract.  Details:   After verbal consent, 4% lidocaine sprayed in the left naris. I advanced the flexible fiberoptic endoscope through the nose and into the nasal cavity.   Nasal Cavity: clear, no lesions, healthy 
 mucosa  Nasopharynx: healthy mucosa, no lesions,   Oropharynx: clear, no lesions, healthy mucosa.  Larynx: Epiglottis slightly edematous. Both true vocal folds are mobile, full abduction and adduction. No evidence of subglottic disease.  Hypopharynx: piriform sinuses, posterior cricoid area, and posterior pharyngeal walls normal.     Pathology Studies: Personally reviewed, with findings as per HPI.    Laboratory Studies: Personally reviewed labs below.    WBC Count   Date/Time Value Ref Range Status   *****/*****/***** *****:***** PM 3.5 3.4 - 10.0 x10E9/L Final     Hemoglobin   Date/Time Value Ref Range Status   *****/*****/***** *****:***** PM 11.9 (L) 13.6 - 17.5 g/dL Final     Hematocrit   Date/Time Value Ref Range Status   *****/*****/***** *****:***** PM 38.2 (L) 41.0 - 53.0 % Final     Platelet Count   Date/Time Value Ref Range Status   *****/*****/***** *****:***** PM ***** ***** - 450 x10E9/L Final      Urea Nitrogen, Serum / Plasma   Date/Time Value Ref Range Status   *****/*****/***** *****:***** PM 26 (H) 7 - 25 mg/dL Final     Sodium, Serum / Plasma   Date/Time Value Ref Range Status   *****/*****/***** *****:***** PM ***** ***** - 145 mmol/L Final     Potassium, Serum / Plasma   Date/Time Value Ref Range Status   *****/*****/***** *****:***** PM 4.6 3.5 - 5.0 mmol/L Final     Carbon Dioxide, Total   Date/Time Value Ref Range Status   *****/*****/***** *****:***** PM 28 22 - 29 mmol/L Final     Chloride, Serum / Plasma   Date/Time Value Ref Range Status   *****/*****/***** *****:***** PM ***** ***** - 110 mmol/L Final     Glucose, non-fasting   Date/Time Value Ref Range Status   *****/*****/***** *****:***** PM 104 70 - 199 mg/dL Final     Comment:     If the patient is fasting, suggests impaired glucose homeostasis     Calcium, total, Serum / Plasma   Date/Time Value Ref Range Status   *****/*****/***** *****:***** PM 10.0 8.4 - 10.5 mg/dL Final     Magnesium, Serum / Plasma   Date/Time Value Ref Range Status   *****/*****/***** *****:***** PM 2.1 1.6 - 2.6 mg/dL Final     Bilirubin, Total   Date/Time Value Ref Range Status   *****/*****/***** *****:***** PM 0.2 0.2 - 1.2 mg/dL 
 Final     AST   Date/Time Value Ref Range Status   *****/*****/***** *****:***** PM 21 5 - 44 U/L Final     Alanine transaminase   Date/Time Value Ref Range Status   *****/*****/***** *****:***** PM 19 10 - 61 U/L Final     Albumin, Serum / Plasma   Date/Time Value Ref Range Status   *****/*****/***** *****:***** PM 4.0 3.4 - 4.8 g/dL Final      Thyroid Stimulating Hormone   Date/Time Value Ref Range Status   *****/*****/***** *****:***** PM 1.73 0.45 - 4.12 mIU/L Final       Radiology Studies: Personally reviewed as per HPI.       Assessment:  ***** ***** is a 67 y.o. male never smoker diagnosed on 08/29/2020 with squamous cell carcinoma of the right base of tongue ***** ***** Stage III, s/p chemoradiation 70 Gy with weekly cisplatin 40 mg/m2 x 5 completed 12/23/2020.      19 mo post CRT, doing well *****.     Plan:  1. CT neck in 6 mo; then can stop surveillance HN imaging and continue with exams/***** testing alone  2. Follow-up Dr. *****  3. Rad onc follow-up in 6 mo    Future Appointments   Date Time Provider Department Center   *****/*****/*****  *****:***** PM ***** ***** *****, MD OHNS HNS ***** PCMB           I spent a total of 30 minutes on this patient's care on the day of their visit excluding time spent related to any billed procedures. This time includes time spent with the patient as well as time spent documenting in the medical record, reviewing patient's records and tests, obtaining history, placing orders, communicating with other healthcare professionals, counseling the patient, family, or caregiver, and/or care coordination for the diagnoses above.         *****, ***** ***** am acting as a chart ***** for services provided by Dr. ***** ***** on 08/06/2022      

